Nonparametric empirical Bayes biomarker imputation and estimation

Biomarkers are often measured in bulk to diagnose patients, monitor patient conditions, and research novel drug pathways. The measurement of these biomarkers often suffers from detection limits that result in missing and untrustworthy measurements. Frequently, missing biomarkers are imputed so that...

Full description

Saved in:
Bibliographic Details
Published inStatistics in medicine Vol. 43; no. 19; pp. 3742 - 3758
Main Authors Barbehenn, Alton, Zhao, Sihai Dave
Format Journal Article
LanguageEnglish
Published Hoboken, USA John Wiley & Sons, Inc 30.08.2024
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Biomarkers are often measured in bulk to diagnose patients, monitor patient conditions, and research novel drug pathways. The measurement of these biomarkers often suffers from detection limits that result in missing and untrustworthy measurements. Frequently, missing biomarkers are imputed so that down‐stream analysis can be conducted with modern statistical methods that cannot normally handle data subject to informative censoring. This work develops an empirical Bayes g$$ g $$‐modeling method for imputing and denoising biomarker measurements. We establish superior estimation properties compared to popular methods in simulations and with real data, providing the useful biomarker measurement estimations for down‐stream analysis.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0277-6715
1097-0258
1097-0258
DOI:10.1002/sim.10150